Albemarle Food Safety Business Launches New Antimicrobial Product
Baton Rouge, LA /PRNewswire - Albemarle Corporation /quotes/zigman/135848/quotes/nls/alb ALB -4.55% , a global developer, manufacturer and marketer of highly engineered specialty chemicals, announces the launch of a new antimicrobial used in meat processing, enhancing the company's food safety portfolio to include a liquid form of hypobromous acid.
CellVex(TM) is a post-harvest antimicrobial proven effective against E. coli, Campylobacter and Salmonella for high volume applications in the meat and poultry markets. With the launch of CellVex, Albemarle can now offer customers two product platforms for hypobromous acid - solid and liquid. CellVex can be used as part of a multiple intervention strategy and is approved in all applications within a meat processing plant.
"Albemarle is dedicated to providing antimicrobial interventions to reduce food-borne pathogens across the globe. We offer unique products and science-based solutions for compliance with various global performance standards including the United States Department of Agriculture Food Safety and Inspection Service's Salmonella and Campylobacter initiative in poultry processing," stated Tina Craft, Global Business Manager, Specialty Bromides.
CellVex joins Albemarle's current food safety products, AviBrom® and BoviBrom®, which are solid forms of hypobromous acid and sold through a partnership with Elanco Food Solutions. Albemarle is the only company in the food safety industry to offer hypobromous acid in a solid form. AviBrom, an antimicrobial processing aid for poultry plants, was the first bromine chemistry solution introduced into meat processing. BoviBrom is a post-harvest antimicrobial rinse for beef processing. All three products are FDA-approved, are efficacious in reducing bacteria and can be applied in a variety of processing applications.
Albemarle utilized its new Research & Development Microbiology Laboratory in Baton Rouge at the Louisiana Business & Technology Center on the LSU South Campus Research Park for the development and testing of CellVex. This state of the art facility, fully staffed with research scientists, specializes in microbiology testing and is equipped to test all food-borne pathogens. As Albemarle expands its product offering, the company is working with key public and private entities to solve global food safety challenges.
Albemarle's Food Safety business is a part of the company's Fine Chemistry global business unit and offers a premium line of bromine-based antimicrobials as a unique solution for the food processing industry. Albemarle's food safety products are some of the fastest growing products used in processing today, proven effective against many pathogenic bacteria such as Salmonella, Campylobacter, Listeria and E. coli.
About Albemarle Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading global developer, manufacturer, and marketer of highly-engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services. The Company is committed to global sustainability and is advancing its eco-practices and solutions in its three business segments, Polymer Solutions, Catalysts and Fine Chemistry. Corporate Responsibility Magazine selected Albemarle to its prestigious "100 Best Corporate Citizens" list for 2010 and 2011. Albemarle employs approximately 4,000 people and serves customers in approximately 100 countries. Albemarle regularly posts information to www.albemarle.com , including notification of events, news, financial performance, investor presentations and webcasts, Regulation G reconciliations, SEC filings, and other information regarding the Company, its businesses and the markets we serve.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.
SOURCE Albemarle Corporation
Copyright (C) 2012 PR Newswire. All rights reserved